Chargement en cours...
Upregulation of ABCG2 by Romidepsin via the Aryl Hydrocarbon Receptor Pathway
Histone deacetylase inhibitors (HDACI) are promising anticancer agents and their use in combination with conventional anticancer drugs is currently under investigation. We previously reported cell line–specific upregulation of ABCG2, a multidrug resistance transporter shown to control oral bioavaila...
Enregistré dans:
| Publié dans: | Mol Cancer Res |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7050650/ https://ncbi.nlm.nih.gov/pubmed/21357443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-10-0270 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|